CLDX logo

Celldex Therapeutics, Inc. (CLDX) Retained Earnings

Annual Retained Earnings:

-$1.56B-$157.86M(-11.30%)
December 31, 2024

Summary

  • As of today, CLDX annual retained earnings is -$1.56 billion, with the most recent change of -$157.86 million (-11.30%) on December 31, 2024.
  • During the last 3 years, CLDX annual retained earnings has fallen by -$411.62 million (-35.99%).
  • CLDX annual retained earnings is now -53528.41% below its all-time high of -$2.90 million, reached on April 30, 1986.

Performance

CLDX Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCLDXbalance sheet metrics

Quarterly Retained Earnings:

-$1.67B-$56.60M(-3.52%)
June 30, 2025

Summary

  • As of today, CLDX quarterly retained earnings is -$1.67 billion, with the most recent change of -$56.60 million (-3.52%) on June 30, 2025.
  • Over the past year, CLDX quarterly retained earnings has dropped by -$199.61 million (-13.62%).
  • CLDX quarterly retained earnings is now -57335.17% below its all-time high of -$2.90 million, reached on April 30, 1986.

Performance

CLDX Quarterly Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCLDXbalance sheet metrics

Retained Earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

CLDX Retained Earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year-11.3%-13.6%
3Y3 Years-36.0%-38.5%
5Y5 Years-53.5%-60.6%

CLDX Retained Earnings Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-36.0%at low-35.5%at low
5Y5-Year-53.5%at low-58.5%at low
All-TimeAll-Time>-9999.0%at low>-9999.0%at low

CLDX Retained Earnings History

DateAnnualQuarterly
Jun 2025
-
-$1.67B(-3.5%)
Mar 2025
-
-$1.61B(-3.5%)
Dec 2024
-$1.56B(-11.3%)
-$1.56B(-3.1%)
Sep 2024
-
-$1.51B(-2.9%)
Jun 2024
-
-$1.47B(-2.5%)
Mar 2024
-
-$1.43B(-2.3%)
Dec 2023
-$1.40B(-11.3%)
-$1.40B(-3.2%)
Sep 2023
-
-$1.35B(-2.9%)
Jun 2023
-
-$1.32B(-2.4%)
Mar 2023
-
-$1.29B(-2.3%)
Dec 2022
-$1.26B(-9.8%)
-$1.26B(-2.2%)
Sep 2022
-
-$1.23B(-2.2%)
Jun 2022
-
-$1.20B(-3.1%)
Mar 2022
-
-$1.17B(-2.0%)
Dec 2021
-$1.14B(-6.6%)
-$1.14B(-1.8%)
Sep 2021
-
-$1.12B(-1.9%)
Jun 2021
-
-$1.10B(-1.2%)
Mar 2021
-
-$1.09B(-1.5%)
Dec 2020
-$1.07B(-5.9%)
-$1.07B(-2.1%)
Sep 2020
-
-$1.05B(-1.4%)
Jun 2020
-
-$1.04B(-1.1%)
Mar 2020
-
-$1.03B(-1.2%)
Dec 2019
-$1.01B(-5.3%)
-$1.01B(-1.0%)
Sep 2019
-
-$1.00B(-1.2%)
Jun 2019
-
-$991.46M(-1.2%)
Mar 2019
-
-$979.68M(-1.8%)
Dec 2018
-$962.44M(-18.5%)
-$962.44M(-1.0%)
Sep 2018
-
-$953.04M(-0.8%)
Jun 2018
-
-$945.79M(-1.8%)
Mar 2018
-
-$929.39M(-14.4%)
Dec 2017
-$812.52M(-12.9%)
-$812.52M(-0.5%)
Sep 2017
-
-$808.68M(-3.4%)
Jun 2017
-
-$782.31M(-3.8%)
Mar 2017
-
-$753.75M(-4.8%)
Dec 2016
-$719.49M(-21.7%)
-$719.49M(-4.7%)
Sep 2016
-
-$687.18M(-4.5%)
Jun 2016
-
-$657.58M(-5.1%)
Mar 2016
-
-$625.63M(-5.9%)
Dec 2015
-$590.96M(-27.4%)
-$590.96M(-5.9%)
Sep 2015
-
-$558.27M(-6.1%)
Jun 2015
-
-$526.29M(-6.6%)
Mar 2015
-
-$493.93M(-6.5%)
Dec 2014
-$463.76M(-34.2%)
-$463.76M(-7.4%)
Sep 2014
-
-$431.94M(-7.0%)
Jun 2014
-
-$403.86M(-7.5%)
Mar 2014
-
-$375.58M(-8.7%)
Dec 2013
-$345.68M(-30.9%)
-$345.68M(-6.8%)
Sep 2013
-
-$323.62M(-7.7%)
Jun 2013
-
-$300.48M(-6.8%)
Mar 2013
-
-$281.46M(-6.6%)
Dec 2012
-$264.13M(-28.8%)
-$264.13M(-6.8%)
Sep 2012
-
-$247.32M(-6.5%)
Jun 2012
-
-$232.29M(-6.3%)
Mar 2012
-
-$218.52M(-6.6%)
Dec 2011
-$205.01M(-28.0%)
-$205.01M(-6.6%)
Sep 2011
-
-$192.27M(-6.5%)
Jun 2011
-
-$180.50M(-6.0%)
Mar 2011
-
-$170.27M(-6.3%)
Dec 2010
-$160.21M(-1.6%)
-$160.21M(+12.4%)
Sep 2010
-
-$182.87M(-5.2%)
Jun 2010
-
-$173.78M(-5.8%)
Mar 2010
-
-$164.26M(-4.2%)
Dec 2009
-$157.67M(-30.1%)
-$157.67M(-8.9%)
Sep 2009
-
-$144.73M(-5.2%)
Jun 2009
-
-$137.56M(-13.5%)
Dec 2008
-$121.15M(-64.5%)
-$121.15M(-6.6%)
Sep 2008
-
-$113.70M(-7.2%)
Jun 2008
-
-$106.04M(-10.7%)
Mar 2008
-
-$95.78M(+65.5%)
Dec 2007
-$73.65M(+71.3%)
-$277.89M(-8.4%)
DateAnnualQuarterly
Dec 2006
-$256.25M(-8.6%)
-$256.25M(-2.5%)
Sep 2006
-
-$250.03M(-2.3%)
Jun 2006
-
-$244.51M(-2.4%)
Mar 2006
-
-$238.84M(-1.3%)
Dec 2005
-$235.87M(-8.3%)
-$235.87M(-1.7%)
Sep 2005
-
-$231.89M(-2.0%)
Jun 2005
-
-$227.38M(-2.1%)
Mar 2005
-
-$222.64M(-4.0%)
Dec 2004
-$217.78M(-6.5%)
-
Sep 2004
-
-$214.08M(-1.8%)
Jun 2004
-
-$210.38M(-1.9%)
Mar 2004
-
-$206.48M(-0.9%)
Dec 2003
-$204.57M(-6.6%)
-$204.57M(-2.0%)
Sep 2003
-
-$200.56M(-1.1%)
Jun 2003
-
-$198.45M(-1.6%)
Mar 2003
-
-$195.26M(-1.8%)
Dec 2002
-$191.90M(-7.8%)
-$191.90M(-1.8%)
Sep 2002
-
-$188.43M(-0.1%)
Jun 2002
-
-$188.15M(-2.8%)
Mar 2002
-
-$182.99M(-2.8%)
Dec 2001
-$178.07M(-14.6%)
-$178.07M(-4.0%)
Sep 2001
-
-$171.22M(-3.8%)
Jun 2001
-
-$164.99M(-3.6%)
Mar 2001
-
-$159.32M(-2.6%)
Dec 2000
-$155.32M(-16.5%)
-$155.32M(-16.5%)
Dec 1999
-$133.35M(-9.3%)
-$133.35M(-2.8%)
Sep 1999
-
-$129.69M(-2.0%)
Jun 1999
-
-$127.13M(-1.9%)
Mar 1999
-
-$124.78M(-2.2%)
Dec 1998
-$122.00M(-73.8%)
-$122.04M(-1.9%)
Sep 1998
-
-$119.72M(-64.1%)
Jun 1998
-
-$72.95M(-1.8%)
Mar 1998
-
-$71.65M(-2.1%)
Dec 1997
-$70.20M(-22.9%)
-$70.20M(-2.0%)
Sep 1997
-
-$68.80M(-13.3%)
Jun 1997
-
-$60.70M(-2.7%)
Mar 1997
-
-$59.10M(-3.5%)
Dec 1996
-$57.10M(-23.3%)
-$57.10M(-4.2%)
Sep 1996
-
-$54.80M(-4.4%)
Jun 1996
-
-$52.50M(-8.9%)
Mar 1996
-
-$48.20M(-4.1%)
Dec 1995
-$46.30M(-21.5%)
-$46.30M(-0.2%)
Sep 1995
-
-$46.20M(-7.2%)
Jun 1995
-
-$43.10M(-6.4%)
Mar 1995
-
-$40.50M(-6.3%)
Dec 1994
-$38.10M(-43.8%)
-$38.10M(-13.1%)
Sep 1994
-
-$33.70M(-9.8%)
Jun 1994
-
-$30.70M(-8.1%)
Mar 1994
-
-$28.40M(-7.2%)
Dec 1993
-$26.50M(-41.7%)
-$26.50M(-9.1%)
Sep 1993
-
-$24.30M(-10.5%)
Jun 1993
-
-$22.00M(-7.8%)
Mar 1993
-
-$20.40M(-17.2%)
Dec 1992
-$18.70M(-23.8%)
-
Oct 1992
-
-$17.40M(-6.7%)
Jul 1992
-
-$16.30M(-7.9%)
Apr 1992
-
-$15.10M(-19.8%)
Apr 1992
-$15.10M(-43.8%)
-
Jan 1992
-
-$12.60M(+4.5%)
Oct 1991
-
-$13.20M(-12.8%)
Jul 1991
-
-$11.70M(-11.4%)
Apr 1991
-$10.50M(-50.0%)
-$10.50M(-10.5%)
Jan 1991
-
-$9.50M(-9.2%)
Oct 1990
-
-$8.70M(-8.8%)
Jul 1990
-
-$8.00M(-14.3%)
Apr 1990
-$7.00M(-16.7%)
-$7.00M(+4.1%)
Jan 1990
-
-$7.30M(-21.7%)
Apr 1989
-$6.00M(-22.4%)
-$6.00M(-22.4%)
Apr 1988
-$4.90M(-32.4%)
-$4.90M(-32.4%)
Apr 1987
-$3.70M(-27.6%)
-$3.70M(-27.6%)
Apr 1986
-$2.90M
-$2.90M

FAQ

  • What is Celldex Therapeutics, Inc. annual retained earnings?
  • What is the all-time high annual retained earnings for Celldex Therapeutics, Inc.?
  • What is Celldex Therapeutics, Inc. annual retained earnings year-on-year change?
  • What is Celldex Therapeutics, Inc. quarterly retained earnings?
  • What is the all-time high quarterly retained earnings for Celldex Therapeutics, Inc.?
  • What is Celldex Therapeutics, Inc. quarterly retained earnings year-on-year change?

What is Celldex Therapeutics, Inc. annual retained earnings?

The current annual retained earnings of CLDX is -$1.56B

What is the all-time high annual retained earnings for Celldex Therapeutics, Inc.?

Celldex Therapeutics, Inc. all-time high annual retained earnings is -$2.90M

What is Celldex Therapeutics, Inc. annual retained earnings year-on-year change?

Over the past year, CLDX annual retained earnings has changed by -$157.86M (-11.30%)

What is Celldex Therapeutics, Inc. quarterly retained earnings?

The current quarterly retained earnings of CLDX is -$1.67B

What is the all-time high quarterly retained earnings for Celldex Therapeutics, Inc.?

Celldex Therapeutics, Inc. all-time high quarterly retained earnings is -$2.90M

What is Celldex Therapeutics, Inc. quarterly retained earnings year-on-year change?

Over the past year, CLDX quarterly retained earnings has changed by -$199.61M (-13.62%)
On this page